1. 홈페이지
  2. 资源与支持
  3. 历年文献

历年文献

历年文献

Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：PHARMACOLOGICAL RESEARCH

RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：Journal for ImmunoTherapy of Cancer

Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：JOURNAL OF NANOBIOTECHNOLOGY

iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：MedComm

Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：Cell Reports Medicine

Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：MOLECULAR THERAPY

Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：Gut Microbes

HDAC6-dependent deacetylation of NGF dictates its ubiquitination and maintains primordial follicle dormancy

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：Theranostics

Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：CANCER RESEARCH

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Model Organisms：마우스 Product & Service：- Research field：

Published date：2024 | References：Cell Discovery

위로